Expertise in
8
conditions

Hanna E. Seppanen

Helsinki, FI 
Expertise in
8
conditions
Helsinki, FI 
OverviewLocationsClinical Research

Overview

Hanna Seppanen practices in Helsinki, Finland. Ms. Seppanen is highly rated in 8 conditions, according to our data. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.

Her clinical research consists of co-authoring 98 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Helsinki, 00014, Finland
Other Locations
Tampere, Finland
Oulu, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Improvement of Care of Patients Undergoing Pancreaticoduodenectomy
Improvement of Care of Patients Undergoing Pancreaticoduodenectomy
Enrollment Status: Completed
Publish Date: March 14, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage? A Prospective Study
Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage? A Prospective Study
Enrollment Status: Withdrawn
Publish Date: May 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?
Enrollment Status: Withdrawn
Publish Date: May 19, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

98 Total Publications

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.
Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.
Journal: NAR molecular medicine
Published: October 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Seppanen's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile